<!doctype html>
<html lang="en">

<head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <title>ABOUT REGISTERING PHARMACEUTICAL PRODUCTS IN LEBANON</title>

    <meta name="title" content="ABOUT REGISTERING PHARMACEUTICAL PRODUCTS IN LEBANON">
    <meta name="description" content="The Ministry of Public Health is Lebanon?s governmental authority in charge of controlling the pharmaceutical sector in the country. So any medicine entering the Lebanese market should undergo an approval and registration process at the Ministry to ensure its safety, efficacy and quality standards.">
    <meta name="keywords" content="PHARMACEUTICAL PRODUCTS IN LEBANON, MINISTRY OF PUBLIC HEALTH, NATIONAL PHARMACEUTICAL STRATEGY">
    <meta name="robots" content="index, follow">
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
    <meta name="revisit-after" content="1 days">
    <meta name="author" content="Fadi ElJurdi">

    <!-- Open Graph / Facebook -->
    <meta property="og:type" content="website">
    <meta property="og:url" content="https://jurdilaw.com/blogs/about-registering-pharmaceutical-products-in-lebanon.html">
    <meta property="og:title" content="ABOUT REGISTERING PHARMACEUTICAL PRODUCTS IN LEBANON">
    <meta property="og:description" content="The Ministry of Public Health is Lebanon?s governmental authority in charge of controlling the pharmaceutical sector in the country. So any medicine entering the Lebanese market should undergo an approval and registration process at the Ministry to ensure its safety, efficacy and quality standards.">
    <meta property="og:image" content="https://lh3.googleusercontent.com/d/1pKX-1T4-qNv1eb84p5P-IB2Nn-WCL_KL">

    <!-- Twitter -->
    <meta property="twitter:card" content="summary_large_image">
    <meta property="twitter:url" content="https://jurdilaw.com/blogs/about-registering-pharmaceutical-products-in-lebanon.html">
    <meta property="twitter:title" content="ABOUT REGISTERING PHARMACEUTICAL PRODUCTS IN LEBANON">
    <meta property="twitter:description" content="The Ministry of Public Health is Lebanon?s governmental authority in charge of controlling the pharmaceutical sector in the country. So any medicine entering the Lebanese market should undergo an approval and registration process at the Ministry to ensure its safety, efficacy and quality standards.">
    <meta property="twitter:image" content="https://lh3.googleusercontent.com/d/1pKX-1T4-qNv1eb84p5P-IB2Nn-WCL_KL">
    <link rel="shortcut icon" href="https://lh3.googleusercontent.com/d/1pKX-1T4-qNv1eb84p5P-IB2Nn-WCL_KL" type="image/x-icon">
    
  
    <!-- CSS -->
    <link rel="shortcut icon" href="favicon.ico" type="image/x-icon">
    <link rel="stylesheet" href="../css/app.css">
    <link href="https://unpkg.com/aos@2.3.1/dist/aos.css" rel="stylesheet">
    
    <!-- JS -->
    <script src="../js/packages/vue.min.js" defer></script>

</head>

<body id="app" class="bg-blocks">
    
    <pagination folder="blogs">ABOUT REGISTERING PHARMACEUTICAL PRODUCTS IN LEBANON</pagination>
    <main class="py-3">
        <section class="container">
            <div class="row g-3">
                <div class="col-12 col-lg-8">
                    <article class="article-container">
                        <blog-header aria-label="blog-header"></blog-header>
                        <blog-media media="undefined"></blog-media>
                        <section class="article-body">
                            <p class="article-p"><span class="blog-badge">BLOG</span><time>{{utilities.timo('Tue, 20 May 2025 22:17:15 GMT')}}</time></p>
                            <h1 class="article-h1">ABOUT REGISTERING PHARMACEUTICAL PRODUCTS IN LEBANON</h1>
                            <aside class="article-aside">
                                <p class="ql-align-center"><strong style="background-color: transparent; color: rgb(0, 0, 0);">ABOUT REGISTERING PHARMACEUTICAL PRODUCTS IN LEBANON</strong></p><p><br></p><p class="ql-align-justify"><span style="background-color: transparent; color: rgb(0, 0, 0);">The </span><a href="https://www.moph.gov.lb/" target="_blank" style="background-color: transparent; color: rgb(17, 85, 204);">Ministry of Public Health</a><span style="background-color: transparent; color: rgb(0, 0, 0);"> is Lebanon?s governmental authority in charge of controlling the pharmaceutical sector in the country. So any medicine entering the Lebanese market should undergo an approval and registration process at the Ministry to ensure its safety, efficacy and quality standards. In accordance with decree 571, 2008, the requirements and steps of this demanding process were detailed in the guide for </span><a href="https://www.moph.gov.lb/userfiles/files/HealthCareSystem/Pharmaceuticals/DrugsandPharmaceuticallikeRegistration/Manuals%26Guidelines/DrugsRegistration2014.pdf" target="_blank" style="background-color: transparent; color: rgb(17, 85, 204);">registering pharmaceutical products</a><span style="background-color: transparent; color: rgb(0, 0, 0);"> both locally manufactured and imported. These products need to be tested, approved by the drug registration technical committee, priced by the pricing committee and granted marketing authorisation as part of the approval decision. This lengthy, bureaucratic and not fully automated process is quite challenging for traders and </span><a href="https://www.moph.gov.lb/en/Pages/3/1460/local-manufacturing-industries" target="_blank" style="background-color: transparent; color: rgb(17, 85, 204);">manufacturers</a><span style="background-color: transparent; color: rgb(0, 0, 0);"> when navigating through its requirements and procedures.&nbsp;</span></p><p><br></p><p><strong style="background-color: transparent; color: rgb(0, 0, 0);">Current situation of the sector&nbsp;</strong></p><p><br></p><p class="ql-align-justify"><span style="background-color: transparent; color: rgb(0, 0, 0);">Against all odds, the financial crisis in Lebanon that started in 2019 followed by the breakout of COVID-19 gave the locally manufactured medicine an opportunity to prove its accessibility and efficiency. The drop in </span><a href="https://www.imf.org/external/datamapper/profile/LBN" target="_blank" style="background-color: transparent; color: rgb(17, 85, 204);">Lebanon's GDP per capita</a><span style="background-color: transparent; color: rgb(0, 0, 0);">, and the </span><a href="https://www.worldbank.org/en/country/lebanon/overview" target="_blank" style="background-color: transparent; color: rgb(17, 85, 204);">rise of poverty</a><span style="background-color: transparent; color: rgb(0, 0, 0);"> to around half the population, forced the local market that was highly reliant on imported brand medicines to seek more affordable local options. In the same context, the drop in imports of pharmaceutical products from around $1.4 billion a year, before these crises, to</span><a href="https://www.trade.gov/country-commercial-guides/lebanon-pharmaceuticals" target="_blank" style="background-color: transparent; color: rgb(17, 85, 204);"> $552 billion in 2022</a><span style="background-color: transparent; color: rgb(0, 0, 0);"> constituted an opportunity for the locally manufactured generic medicines to fill the gap.&nbsp;</span></p><p><br></p><p class="ql-align-justify"><span style="background-color: transparent; color: rgb(0, 0, 0);">Unfortunately neither the laws nor the government were able to meet these developments and lead the local industry to more progress. The absence so far of a </span><a href="https://scholarworks.aub.edu.lb/bitstream/handle/10938/29436/2023-1161.pdf?sequence=1&amp;isAllowed=y" target="_blank" style="background-color: transparent; color: rgb(17, 85, 204);">National Pharmaceutical Strategy</a><span style="background-color: transparent; color: rgb(0, 0, 0);">, that would lift </span><a href="https://legal-agenda.com/5-%D9%85%D8%B3%D8%AA%D9%88%D8%B1%D8%AF%D9%8A%D9%86-%D9%8A%D8%AD%D8%AA%D9%83%D8%B1%D9%88%D9%86-%D8%A3%D9%83%D8%AB%D8%B1-%D9%85%D9%86-%D9%86%D8%B5%D9%81-%D8%A7%D9%84%D8%B3%D9%88%D9%82-%D8%A7%D9%84/" target="_blank" style="background-color: transparent; color: rgb(17, 85, 204);">monopolies</a><span style="background-color: transparent; color: rgb(0, 0, 0);">, amend </span><a href="http://77.42.251.205/parliament/P23/2020/P2020N24/0025.html" target="_blank" style="background-color: transparent; color: rgb(17, 85, 204);">subsidies</a><span style="background-color: transparent; color: rgb(0, 0, 0);"> and activate the Central Drug Quality Laboratory, the sector continues to shape itself in light of the economic and social developments in the country.&nbsp;</span></p><p><br></p><p><strong style="background-color: transparent; color: rgb(0, 0, 0);">Registration process</strong></p><p><br></p><p class="ql-align-justify"><span style="background-color: transparent; color: rgb(0, 0, 0);">The pharmaceutical registration process is mainly about the requirements of the product dossier to be submitted by the applicant and the registration procedure taken by the Ministry of Public Health to accept the application or reject it. The application dossier should include the administrative details of the registering party and the product and the technical information thereof. Regarding the timelines, some sources expected the process to take between </span><a href="https://omcmedical.com/lebanon-drug-product-registration/" target="_blank" style="background-color: transparent; color: rgb(17, 85, 204);">6 to 12 months</a><span style="background-color: transparent; color: rgb(0, 0, 0);">. As for the fees, decree 571, 2008 set the registration fees for the process with a first payment (2x minimum wage) settled by the time of the application submission and a second payment (5x minimum wage) settled by the time of the registration.&nbsp;</span></p><p><br></p><p class="ql-align-justify"><span style="background-color: transparent; color: rgb(0, 0, 0);">Although </span><a href="https://www.moph.gov.lb/userfiles/files/HealthCareSystem/Pharmaceuticals/DrugsandPharmaceuticallikeRegistration/Karar504-1999.pdf" target="_blank" style="background-color: transparent; color: rgb(17, 85, 204);">Minister decision 504, 1999</a><span style="background-color: transparent; color: rgb(0, 0, 0);"> requested the technical committee to handle dossiers of locally manufactured products separately from dossiers of imported medicines, the requirements for registration are similar except for a few additional documents related to the manufacturing and marketing parties of imported medicines.&nbsp;</span></p><p><br></p><p class="ql-align-justify"><span style="background-color: transparent; color: rgb(0, 0, 0);">On the list of additional information, the product dossier should include any patent registration information. This process is handled by the </span><a href="https://economy.gov.lb/public/uploads/files/6061_8660_6573.pdf" target="_blank" style="background-color: transparent; color: rgb(17, 85, 204);">Intellectual Property Protection Office </a><span style="background-color: transparent; color: rgb(0, 0, 0);">at the Ministry of Economy and Trade and requires support by specialised firms to navigate it effectively .</span></p><p><br></p><p><strong style="background-color: transparent; color: rgb(0, 0, 0);">Bottlenecks and obstacles</strong></p><p><br></p><p><span style="background-color: transparent; color: rgb(0, 0, 0);">Both importers and manufacturers can face obstacles in the registration process with the Lebanese authorities. For foreign imported medicines:&nbsp;</span></p><ul><li><span style="background-color: transparent;">Translating the dossier documentations to arabic and acquiring necessary attestations is consuming.</span></li><li><span style="background-color: transparent;">Missing information in the application might cause a series of delays and postpone the targeted release date.</span></li></ul><p class="ql-align-justify"><span style="background-color: transparent; color: rgb(0, 0, 0);">On the other hand, both importers and manufacturers should deal with administrative bureaucracy and inefficiency if they surface at any point during the process. The importer and manufacturer has the right by the law to contest the decision of the technical committee or the pricing committee, and this process as well has its procedural requirements by the law, but could also necessitate expert support.</span></p><p><br></p><p><strong style="background-color: transparent; color: rgb(0, 0, 0);">Takeaway&nbsp;</strong></p><p><br></p><p><span style="background-color: transparent; color: rgb(0, 0, 0);">In light of the current situation in the country, it is unlikely that major regulatory reforms in the pharmaceutical sector will take place in the near future. However, a few changes in the current regulations might bring about needed advancements in the sector. Activating the national Drug Quality Laboratory would increase trust in the local product and improve its exports within the region. Imported medicine needs more certainty in relation to Central bank subsidies and more control on crossborder snuggling. Until those are achieved, counting on expert support will certainly make processes smoother.&nbsp; </span></p><p><br></p><p>&amp;#xa9; Jurdi &amp; Co</p>
                            </aside>
                        </section>
                        <blog-footer aria-label="blog-footer"></blog-footer>
                    </article>
                </div>
                <div class="col-12 col-lg-4">
                    <check-also></check-also>
                </div>
            </div>
        </section>
    </main>
    <footer-section></footer-section>
    
    <!-- JAVASCRIPT -->
    <script src="https://unpkg.com/aos@2.3.1/dist/aos.js"></script>
    <script type="module" src="../js/app.js"></script>
    
</body>

</html>